Exergaming in People With Major Neurocognitive Disorder
The Efficacy of Exergaming in People With Major Neurocognitive Disorder Residing in Long-term Care Facilities: A Randomized Controlled Trial
1 other identifier
interventional
50
1 country
1
Brief Summary
This randomized controlled trial explores the efficacy of an 8-week standing exergaming program in people with major neurocognitive disorder (MNCD) residing in long-term care facilities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 2, 2019
CompletedFirst Submitted
Initial submission to the registry
June 3, 2020
CompletedFirst Posted
Study publicly available on registry
June 18, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2020
CompletedJune 18, 2020
June 1, 2020
1.7 years
June 3, 2020
June 15, 2020
Conditions
Outcome Measures
Primary Outcomes (6)
MoCA
Montréal Cognitive Assessment
2 years
SPPB
Short Physical Performance Battery
2 years
NPI
Neuropsychiatric Inventory
2 years
CSDD
Cornell Scale for Depression in Dementia
2 years
DQOL
Dementia Quality of Life
2 years
(I)ADL
Activities of daily living
2 years
Study Arms (2)
Intervention
EXPERIMENTALDividat senso exergame device
Control
ACTIVE COMPARATORListening to music
Interventions
Eligibility Criteria
You may qualify if:
- a Diagnostic and Statistical Manual of Mental Disorders (DSM) 5 diagnosis of MNCD (American Psychiatric Association, 2013)
- aged 65 years or older
- a score of minimum 10 on the Mini-Mental State Examination (MMSE)
- being physically capable of doing standing exercises (whether or not with extra support).
- Possible causes of MNCD were vascular dementia, Alzheimer's disease, mixed dementia, Parkinson's disease or Lewy body disease.
You may not qualify if:
- any unstable cardiovascular or other health condition which according to the American College of Sports Medicine Standards might lead to unsafe participation
- a score lower than 10 on the MMSE
- a planned transfer to another setting within the following two months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Davy Vancampfortlead
Study Sites (1)
Long-term care facility 'de Wingerd'
Leuven, Vlaams Brabant, 3000, Belgium
Related Publications (1)
Swinnen N, Vandenbulcke M, de Bruin ED, Akkerman R, Stubbs B, Firth J, Vancampfort D. The efficacy of exergaming in people with major neurocognitive disorder residing in long-term care facilities: a pilot randomized controlled trial. Alzheimers Res Ther. 2021 Mar 30;13(1):70. doi: 10.1186/s13195-021-00806-7.
PMID: 33785077DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 3, 2020
First Posted
June 18, 2020
Study Start
January 2, 2019
Primary Completion
September 30, 2020
Study Completion
September 30, 2020
Last Updated
June 18, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will not share